ATI RN
Immune System Drugs Questions
Question 1 of 5
The nurse is preparing to administer routine, recommended immunizations to an immunocompromised 1-year-old child. What is the most important information to know before administering a vaccination?
Correct Answer: A
Rationale: The correct answer is A because knowing the type of vaccine is crucial for immunocompromised children to ensure the vaccine is appropriate and safe. For an immunocompromised child, certain live vaccines may be contraindicated due to the risk of causing severe infections. Option B is not as critical as the type of vaccine. Option C, while important, does not address the specific safety concerns for an immunocompromised child. Option D is also important but does not directly impact the safety of the upcoming vaccination. Therefore, understanding the type of vaccine is the most crucial information before administering it to an immunocompromised child.
Question 2 of 5
The health care provider plans to inject an interferon directly into the patient's wart. What interferon will the nurse prepare?
Correct Answer: C
Rationale: Rationale: The correct answer is C: Interferon alfa n3 (Alferon N). Alferon N is specifically approved for treating viral warts. Interferon alfa 2a (A) is used for chronic hepatitis B/C. Interferon alfacon 1 (B) is for hepatitis C. Interferon beta 1a (D) is for multiple sclerosis. Alferon N is the most appropriate choice for wart treatment.
Question 3 of 5
The nurse has an order to administer oprelvekin (Neumega) to a patient for the first time. Before administering the drug, what allergy would the nurse want to specifically question the patient about?
Correct Answer: B
Rationale: The correct answer is B: Escherichia coli-produced products. Oprelvekin is a recombinant human interleukin-11 produced in Escherichia coli bacteria. Therefore, the nurse should specifically question the patient about any allergies to Escherichia coli-produced products before administering the drug. A: Egg products - Not relevant to oprelvekin. C: Lactose intolerance - Not relevant to oprelvekin. D: Penicillin - Not relevant to oprelvekin.
Question 4 of 5
A patient who is receiving an immune suppressant has been admitted to the unit. What would be a priority action by the nurse?
Correct Answer: C
Rationale: The correct answer is C because protecting the patient from exposure to infection is a priority for a patient receiving immune suppressants. Immune suppressants weaken the body's immune system, making the patient more vulnerable to infections. This action helps prevent complications and promotes patient safety. Monitoring nutritional status (A) is important but not as urgent as preventing infections. Providing patient teaching (B) and support for adverse effects (D) are important but secondary to preventing infections in a patient on immune suppressants.
Question 5 of 5
A 70-year-old patient with acute myelocytic leukemia is receiving sargramostim (Leukine). What is a priority nursing action for this patient?
Correct Answer: B
Rationale: The correct answer is B: Increasing fluids. This is because sargramostim can cause fluid retention and capillary leak syndrome, leading to fluid overload. By increasing fluids, the nurse can help prevent complications such as pulmonary edema. Providing a quiet environment (A), comfort measures for nausea (C), and encouraging dietary intake (D) are important but not the priority in this case. Increasing fluids takes precedence due to the potential serious adverse effects of sargramostim.